{"id":"W3212627725","doi":"10.1182/blood-2021-153657","title":"A Phase I/II Study of Venetoclax in Combination with ASTX727 (cedazuridine/decitabine) in Treatment-Naïve High-Risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Decitabine; Chronic myelomonocytic leukemia; Venetoclax; Myelodysplastic syndromes; Medicine; Azacitidine; Internal medicine; Leukemia; Oncology; Bone marrow; Chronic lymphocytic leukemia; Biology; Genetics; DNA methylation","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001169638,0.001348124,0.001735736,0.000368364,0.0004331626,0.0008807426,0.0007858977,0.001199839,0.004423631],"category_scores_gemma":[0.0005556555,0.0006023952,0.001193715,0.0003972006,0.000985534,0.0006670309,0.0002540423,0.002975417,0.0008419256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007813285,"about_ca_system_score_gemma":0.001737134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001177158,"about_ca_topic_score_gemma":0.002924939,"domain_scores_codex":[0.99972,0.000129054,0.00001152062,0.0000567027,0.00002359799,0.00005900795],"domain_scores_gemma":[0.9995525,0.00005653652,0.00006432537,0.00004223057,0.00003588693,0.0002484342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7012949,0.1431571,0.003135557,0.001057452,0.001139981,0.000276876,0.0002899073,0.002487083,0.08292527,0.0003321533,0.003640321,0.06026339],"study_design_scores_gemma":[0.4605736,0.5274488,0.004750284,0.0000318202,0.0004329594,0.0001659595,0.00005736026,0.0008024616,0.003780968,0.0001451586,0.001786608,0.00002393609],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920454,0.001495894,0.0006327999,0.0003095534,0.0001447643,0.002998861,0.0009245141,0.00009610043,0.001352239],"genre_scores_gemma":[0.9860925,0.001866477,0.002167617,0.0006855786,0.0001634064,0.003266234,0.001923689,0.00003281939,0.003801737],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004423631,"threshold_uncertainty_score":0.01479846,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01998827595166818,"score_gpt":0.2953549840939761,"score_spread":0.2753667081423079,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}